Tower Research Capital LLC (Trc) Aadi Bioscience, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 414 shares of AADI stock, worth $790. This represents 0.0% of its overall portfolio holdings.
Number of Shares
414
Previous 1,793
76.91%
Holding current value
$790
Previous $3,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.6MCall Options Held
15KPut Options Held
3.1K-
Avoro Capital Advisors LLC New York, NY2.85MShares$5.44 Million0.13% of portfolio
-
Qvt Financial LP New York, NY2.31MShares$4.42 Million0.72% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$4.01 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$3.53 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$2.19 Million1.96% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $40.1M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...